Barbara M. Davit - Concepedia

Author

Barbara M. Davit

United States Food and Drug Administration ORCID

Also Known As

B DAVIT, B Davit, B. Davit, B. M. Davit, Barbara Davit, Barbara M Davit, Barbara M. Davit, Barbara Myers Davit

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research Pfizer (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)The University of Texas at Austin

About

Barbara M. Davit is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.1K
2	Biomedical Engineering	2	2	139
3	Engineering	1	1	83
4	Health Sciences	1	1	51
5	Public Health	1	1	31

Barbara M. Davit

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Dissolution Testing for Generic Drugs: An FDA Perspective Om Anand, Lawrence X. Yu, Dale P. Conner, The AAPS Journal Drug AnalysisBioequivalenceDrug PurityPharmacologyAnalytical Chemistry	2011	260
Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development Xinyuan Zhang, Robert Lionberger, Barbara M. Davit, The AAPS Journal Physiologically Based PharmacokineticsDrug DesignDrug DiscoveryBioanalysisMedicine	2011	127
Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications Barbara M. Davit, Dale P. Conner, Beth Fabian-Fritsch, The AAPS Journal BioequivalencePharmacologyBioequivalence Data SubmittedHighly Variable DrugsMedicine	2008	127
In vitro–In Vivo Correlations: Tricks and Traps J Cardot, Barbara M. Davit The AAPS Journal Signal TransductionIn Vivo SystemCell CultureIn Vitro ModelsMedicine	2012	117
Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs Sam Haidar, Fairouz Makhlouf, Donald J. Schuirmann, The AAPS Journal Pharmacokinetic ModelingBioequivalenceMedicineBioanalysisScaling Approach	2008	101
Novel bioequivalence approach for narrow therapeutic index drugs LX Yu, Wenlei Jiang, Xinyuan Zhang, Clinical Pharmacology & Therapeutics	2014	88
The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation Wenlei Jiang, Stephanie Kim, Xinyuan Zhang, International Journal of Pharmaceutics Systems PharmacologySystems BiologyEngineeringPharmacokinetic ModelingPredictive Toxicology	2011	83
FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug‐Drug Interactions: Impact on Labeling Barbara M. Davit, Kellie S. Reynolds, Rae Yuan, The Journal of Clinical Pharmacology	1999	73
Impact of Biopharmaceutics Classification System-Based Biowaivers Jack Cook, Barbara M. Davit, James E. Polli Molecular Pharmaceutics PharmacotherapyBcs Class IiiDrug ResistanceTranslational MedicineBiosignal Processing	2010	51
Food effects in paediatric medicines development for products Co-administered with food Hannah Batchelor, Ann Marie Kaukonen, Sandra Klein, International Journal of Pharmaceutics NutritionInfant NutritionPediatricsChild NutritionFood Effects	2017	31

Page 1